MedTrace Logo

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

NCT06629623 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 310

Last updated 2024-10-08

No results posted yet for this study

Summary

The goal of this observational study is to explore current status of diagnosis, treatment and quality of life for patients with idiopathic pulmonary fibrosis. It aims to integrate qualitative and quantitative data to describe the distribution of perspective, experience, patient journey, treatment, expectation and quality of life for patients with idiopathic pulmonary fibrosis.

Participants will be invited to participate the interview, and answer quantitative survey questions about their quality of life.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • Beijing Chao Yang Hospital

    collaborator OTHER

  • Zhejiang Chinese Medical University

    collaborator OTHER_GOV

  • West China Hospital

    collaborator OTHER

  • Peking University Shenzhen Hospital

    collaborator OTHER

  • Chu Hongling

    lead OTHER

Principal Investigators

  • Hongling Chu, PhD · Peking University Third Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06629623 on ClinicalTrials.gov